Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Shoaibi A, Lloyd PC, Wong HL, Clarke TC, Chillarige Y, Do R, Hu M, Jiao Y, Kwist A, Lindaas A, Matuska K, McEvoy R, Ondari M, Parulekar S, Shi X, Wang J, Lu Y, Obidi J, Zhou CK, Kelman JA, Forshee RA, Anderson SA. Shoaibi A, et al. Among authors: chillarige y. Vaccine. 2023 Jul 19;41(32):4666-4678. doi: 10.1016/j.vaccine.2023.06.014. Epub 2023 Jun 14. Vaccine. 2023. PMID: 37344261 Free PMC article.
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Lloyd PC, Hu M, Wong HL, Shoaibi A, Ke Zhou C, Lo AC, Amend K, Beachler DC, McMahill-Walraven CN, Smith ER, Seeger J, Secora A, Audrey Djibo D, Obidi J, Feng Y, Song J, Reich C, Harris C, Akhtar S, Clifford R, Selvam N, Pigoga JL, Jiao Y, Chillarige Y, MaCurdy T, Forshee R, Anderson SA. Lloyd PC, et al. Among authors: chillarige y. Vaccine. 2022 Oct 26;40(45):6481-6488. doi: 10.1016/j.vaccine.2022.09.060. Epub 2022 Sep 27. Vaccine. 2022. PMID: 36195472 Free PMC article.
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Moll K, Lufkin B, Fingar KR, Ke Zhou C, Tworkoski E, Shi C, Hobbi S, Hu M, Sheng M, McCarty J, Shangguan S, Burrell T, Chillarige Y, Beers J, Saunders-Hastings P, Muthuri S, Edwards K, Black S, Kelman J, Reich C, Amend KL, Djibo DA, Beachler D, Ogilvie RP, Secora A, McMahill-Walraven CN, Seeger JD, Lloyd P, Thompson D, Dimova R, MaCurdy T, Obidi J, Anderson S, Forshee R, Wong HL, Shoaibi A. Moll K, et al. Among authors: chillarige y. Vaccine. 2023 Jan 9;41(2):333-353. doi: 10.1016/j.vaccine.2022.11.003. Epub 2022 Nov 8. Vaccine. 2023. PMID: 36404170 Free PMC article.
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.
Wong HL, Tworkoski E, Ke Zhou C, Hu M, Thompson D, Lufkin B, Do R, Feinberg L, Chillarige Y, Dimova R, Lloyd PC, MaCurdy T, Forshee RA, Kelman JA, Shoaibi A, Anderson SA. Wong HL, et al. Among authors: chillarige y. Vaccine. 2023 Jan 9;41(2):532-539. doi: 10.1016/j.vaccine.2022.11.069. Epub 2022 Dec 1. Vaccine. 2023. PMID: 36496287 Free PMC article.
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
Wong HL, Hu M, Zhou CK, Lloyd PC, Amend KL, Beachler DC, Secora A, McMahill-Walraven CN, Lu Y, Wu Y, Ogilvie RP, Reich C, Djibo DA, Wan Z, Seeger JD, Akhtar S, Jiao Y, Chillarige Y, Do R, Hornberger J, Obidi J, Forshee R, Shoaibi A, Anderson SA. Wong HL, et al. Among authors: chillarige y. Lancet. 2022 Jun 11;399(10342):2191-2199. doi: 10.1016/S0140-6736(22)00791-7. Lancet. 2022. PMID: 35691322 Free PMC article.
43 results